[High-sensitivity troponin assay: biochemistry and clinical application]

Area of Science:

• Biochemistry
• Cardiology
• Clinical Diagnostics

Context:

• Cardiac troponin is the gold standard biomarker for diagnosing acute coronary syndrome (ACS).
• Traditional troponin assays have limitations including delayed detection post-ischemia and difficulty differentiating ischemic from non-ischemic cardiac damage.
• Advancements in assay technology are crucial for improving ACS diagnosis and patient outcomes.

Purpose:

• To evaluate the benefits of high-sensitivity troponin (hs-cTn) assays in clinical practice.
• To discuss the diagnostic capabilities and limitations of traditional troponin assays.
• To highlight the importance of serial troponin measurements in identifying ischemic events.

Summary:

• High-sensitivity troponin assays offer improved sensitivity and specificity compared to older biomarkers like creatine kinase-MB.
• These advanced assays can detect lower troponin concentrations, even in healthy individuals, facilitating earlier diagnosis of myocardial ischemia.
• Distinguishing ischemic from non-ischemic cardiac damage relies on observing a characteristic rising and falling pattern of troponin levels.

Impact:

• Earlier and more accurate diagnosis of acute coronary syndrome, leading to timely treatment and improved patient prognosis.
• Potential for reduced misdiagnosis and unnecessary interventions by better differentiating cardiac injury types.
• Further research is needed to establish the prognostic value of low troponin levels and refine cutoff values for optimal clinical application.